株価
1.19
毎日の変更
-0.02 -1.25%
毎月
-10.23%
毎年
-53.53%
Q1 予測
1.15




現金と同等 変化する 日付
ALKERMES USD 388.57M 227.88M 2025-12
Alnylam Pharmaceuticals USD 1.66B 167M 2025-12
Amarin USD 122.8M 25.08M 2025-09
ANI Pharmaceuticals USD 285.58M 22.98M 2025-12
Anika Therapeutics USD 57.99M 4.82M 2025-09
Arrowhead Research USD 201.64M 112.94M 2025-12
Eisai JPY 301.65B 16.27B 2025-09
Emergent BioSolutions USD 111.7M 23.9M 2023-12
Esperion Therapeutics USD 92.45M 6.39M 2025-09
GlaxoSmithKline GBP 3.3B 303M 2025-09
Heron Therapeutics USD 43.07M 26.55M 2025-09
Insmed USD 510.44M 175.68M 2025-12
Ligand Pharmaceuticals USD 174.93M 489.59M 2025-12
Merck USD 18.17B 10.16B 2025-09
Nektar Therapeutics USD 41.03M 1.96M 2025-09
Neurocrine Biosciences USD 713M 372.8M 2025-12
Omeros USD 1.9M 2.36M 2025-06
Pacira USD 158.54M 10.96M 2025-12
Regeneron Pharmaceuticals USD 18.87B 16.36B 2025-12
Roche Holding CHF 7.55B 579M 2025-06
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Surmodics USD 36.11M 11.81M 2024-09
Ultragenyx Pharmaceutical USD 202.51M 36.4M 2025-09
Veracyte USD 362.58M 47M 2025-12
Vertex Pharmaceuticals USD 6.61B 321.1M 2025-12


Heron Therapeutics 現金と同等 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Mar 2026.